BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21450690)

  • 1. Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells.
    Guo N; Chen R; Li Z; Liu Y; Cheng D; Zhou Q; Zhou J; Lin Q
    Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):354-61. PubMed ID: 21450690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
    Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
    Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
    Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma.
    Chen RF; Li ZH; Zou SQ; Chen JS
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):71-4. PubMed ID: 15730924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.
    Wang SH; Liu NH; Wang J; Bai H; Mao L
    Chin Med J (Engl); 2008 Sep; 121(17):1712-21. PubMed ID: 19024105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
    Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
    Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells.
    Obama K; Satoh S; Hamamoto R; Sakai Y; Nakamura Y; Furukawa Y
    Clin Cancer Res; 2008 Mar; 14(5):1333-9. PubMed ID: 18316552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
    Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nuclear factor kappa B in hepatitis C virus core gene transfected cholangiocarcinoma cells.
    Liu X; Zou S; Qiu F
    Chin Med J (Engl); 2002 Jul; 115(7):998-1001. PubMed ID: 12150729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
    Li T; Li D; Cheng L; Wu H; Gao Z; Liu Z; Jiang W; Gao YH; Tian F; Zhao L; Wang S
    Ann Surg Oncol; 2010 Jul; 17(7):1937-44. PubMed ID: 20162464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3.
    Zeng B; Li Z; Chen R; Guo N; Zhou J; Zhou Q; Lin Q; Cheng D; Liao Q; Zheng L; Gong Y
    FEBS Lett; 2012 Sep; 586(19):3271-8. PubMed ID: 22819820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. si-DNMT1 restore tumor suppressor genes expression through the reversal of DNA hypermethylation in cholangiocarcinoma.
    Xiang J; Luo F; Chen Y; Zhu F; Wang J
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):181-9. PubMed ID: 24361215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma.
    Yang B; House MG; Guo M; Herman JG; Clark DP
    Mod Pathol; 2005 Mar; 18(3):412-20. PubMed ID: 15467712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of epigenetic alterations in cholangiocarcinoma.
    Tischoff I; Wittekind C; Tannapfel A
    J Hepatobiliary Pancreat Surg; 2006; 13(4):274-9. PubMed ID: 16858537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
    Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
    Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
    Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
    J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance.
    Liu XF; Zhu SG; Zhang H; Xu Z; Su HL; Li SJ; Zhou XT
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):449-53. PubMed ID: 16911948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma.
    Chen YJ; Tang QB; Zou SQ
    World J Gastroenterol; 2005 Mar; 11(9):1333-8. PubMed ID: 15761971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.